REGENERON ANTIBODIES IN DEMAND AFTER TRUMP COVID-19 TREATMENT
Patients are asking to join clinical trials of antibody-based COVID-19 drugs after US President Donald Trump was treated last week with an experimental therapy from Regeneron Pharmaceuticals, and on Wednesday and promised to make it free to Americans while touting its benefits.
Medical experts said more data is needed to assess the treatment’s efficacy before wider use should be allowed.
Trump was discharged from the hospital late on Monday, just a few days after being diagnosed with COVID-19 that caused enough lung inflammation for blood oxygen levels to fall.
According to his doctor, blood tests on Monday detected infection-fighting antibodies, which a Regeneron spokesperson said were probably from the treatment.